Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: BMRN stock price vs BKR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BKR's multiple
Needs BKR P/E.
Implied fair value · at BMRN's multiple
Needs BMRN P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: BMRN FY 2025 (ended Dec 31, 2025) · BKR FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
BIOMARIN PHARMACEUTICAL INC · implied price per share
Bear
$25.74
Base
$30.28
Bull
$34.82
Baker Hughes Company · implied price per share
Bear
$25.56
Base
$30.07
Bull
$34.58
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.06x
0.32x
Net debt / EBITDA
Leverage against operating earnings
-3.03x
-0.31x
Cash and equivalents
Liquid reserves on the balance sheet
$2.11B
$7.42B
Total debt
Interest-bearing obligations outstanding
$347.22M
$6.09B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
VERTEX PHARMACEUTICALS INC / MA
BMRN vs VRTX
ALNYLAM PHARMACEUTICALS, INC.
BMRN vs ALNY
Sarepta Therapeutics, Inc.
BMRN vs SRPT
REGENXBIO Inc.
BMRN vs RGNX
IONIS PHARMACEUTICALS INC
BMRN vs IONS
PTC THERAPEUTICS, INC.
BMRN vs PTCT
HALLIBURTON CO
BMRN vs HAL
SCHLUMBERGER LIMITED/NV
BMRN vs SLB
NOV Inc.
BMRN vs NOV
TechnipFMC plc
BMRN vs FTI
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
